Roundhill GLP-1 & Weight Loss ETF
OZEM
#3039
ETF rank
$56.09 M
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ US
Market
$30.65
Share price
-2.22%
Change (1 day)
3.91%
Change (1 year)
Roundhill GLP-1 & Weight Loss ETF (OZEM) provides exposure to companies developing innovative GLP-1 and other weight loss therapies.

Roundhill GLP-1 & Weight Loss ETF - Holdings

Etf holdings as of November 3, 2026Number of holdings: 27

Full holdings list

Weight %NameTickerShares Held
15.62%
Eli Lilly & CoLLY6191
11.94%
Novo Nordisk A/SNVO165112
8.34%
Pfizer IncPFE152119
5.54%
Kailera Therapeutics IncKLRA255223
5.17%
CSPC Pharmaceutical Group Ltd1093 HK2874000
5.12%
Chugai Pharmaceutical Co Ltd4519 JP66100
4.87%
Amgen IncAMGN5847
4.54%
Viking Therapeutics IncVKTX94629
4.41%
AstraZeneca PLCAZN13221
3.72%
Hanmi Pharm Co Ltd128940 KS6624
3.64%
Roche Holding AGROP SW4198
3.35%
Zealand Pharma A/SZEAL DC53985
2.95%
Jiangsu Hengrui Pharmaceuticals Co Ltd1276 HK256800
2.65%
Hansoh Pharmaceutical Group Co Ltd3692 HK364000
2.54%
United Laboratories International Holdings Ltd/The3933 HK1612000
2.52%
Ascletis Pharma Inc1672 HK2327000
2.13%
Gubra A/SGUBRA DC26808
2.12%
Gilead Sciences IncGILD6957
2.06%
Innovent Biologics Inc1801 HK112000
1.95%
MBX Biosciences IncMBX20094
1.63%
Structure Therapeutics IncGPCR44536
1.45%
Rhythm Pharmaceuticals IncRYTM8702
1.40%
Shionogi & Co Ltd4507 JP41000
0.27%
Wave Life Sciences IncWVE43689
0.27%
Cash & OtherCash&Other152798.01
0.24%
First American Government Obligations Fund 12/01/2031FGXXX131626.2
-0.47%
SWISS FRANCCHF-215321.29